Expression of the platelet-derived growth factor receptor in prostate cancer and treatment implications with tyrosine kinase inhibitors.
about
A review of the past, present, and future directions of neoplasiaComing of Age in the Life ofNeoplasia: Where We Have Been and Where We Are GoingPlatelet-derived growth factor receptor/platelet-derived growth factor (PDGFR/PDGF) system is a prognostic and treatment response biomarker with multifarious therapeutic targets in cancers.MP470, a novel receptor tyrosine kinase inhibitor, in combination with Erlotinib inhibits the HER family/PI3K/Akt pathway and tumor growth in prostate cancerThe alpha-receptor for platelet-derived growth factor confers bone-metastatic potential to prostate cancer cells by ligand- and dimerization-independent mechanisms.PDGF upregulates Mcl-1 through activation of β-catenin and HIF-1α-dependent signaling in human prostate cancer cells.Phase II study of dasatinib in patients with metastatic castration-resistant prostate cancerCharacterization of the G-quadruplexes in the duplex nuclease hypersensitive element of the PDGF-A promoter and modulation of PDGF-A promoter activity by TMPyP4Targeted therapy of cancer: new roles for pathologists--prostate cancer.The SCF/c-KIT system in the male: Survival strategies in fertility and cancer.Paradoxical and contradictory effects of imatinib in two cell line models of hormone-refractory prostate cancer.A phase II trial of imatinib mesylate in patients with biochemical relapse of prostate cancer after definitive local therapy.
P2860
Q28389391-EB0E7A1A-8EEA-4678-A6CA-4AB0E54E312AQ28389985-073898F4-861D-4821-9A35-50AD31B8039BQ28395095-3BA508FE-5EB8-4936-B441-E7B9D1D9C19AQ30250273-9340765F-77DC-4BA2-9B03-D563A511F8C2Q33443571-047D5203-B1B7-4D8D-AC20-374231F28FDEQ33874232-B7BACAB9-026F-4EFB-A7C9-332EBF58B4E2Q34140712-A00CCEC7-B8AB-4CDF-81FA-C87965B91B7BQ34613941-669AB34C-A31B-4D83-A590-1C37CD3D59FBQ36360588-FE7FB125-A5EB-4959-A3AD-AF8F96390F2CQ37147772-44ED2F77-1727-47CE-B58E-515622B6C1B9Q38264052-28C398FB-258D-4186-8EE8-0D77BAC6A63BQ38897955-723E51CB-4ED8-4929-9B96-45BE2676B11BQ46041319-50133576-97DA-4AC0-AD91-C98F8B3288F5
P2860
Expression of the platelet-derived growth factor receptor in prostate cancer and treatment implications with tyrosine kinase inhibitors.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Expression of the platelet-der ...... th tyrosine kinase inhibitors.
@en
type
label
Expression of the platelet-der ...... th tyrosine kinase inhibitors.
@en
prefLabel
Expression of the platelet-der ...... th tyrosine kinase inhibitors.
@en
P2093
P2860
P356
P1433
P1476
Expression of the platelet-der ...... th tyrosine kinase inhibitors.
@en
P2093
Alice Fecko
Arul M Chinnaiyan
Matthias D Hofer
Ronglai Shen
Scott A Tomlins
Sunita R Setlur
P2860
P304
P356
10.1593/NEO.04157
P577
2004-09-01T00:00:00Z